Global CAR T Cell Therapy Market Report By Targeted Antigen (CD 19, CD 20, GD2, CD22, CD30, CD33, HER1, HER2, Meso, Egfrvlll And Others), By Therapeutic Application (Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Non Hodgkin Leukemia, Multiple Myeloma, Pancreatic Cancer, Neuroblasta, Breast Cancer, Acute Myeloid Leukemia, Hepatocellular, Carcinoma, Colorectal Cancer And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2020-2027

ID:VMR11210077
July 2021
Report Formats:
Global CAR T Cell Therapy Market Overview

CAR-T (Chimeric antigen receptor T) cells therapy is emerging as a promising approach for treating blood cancer. It is recognized as a new transformative type of cancer treatment that uses the immune system to fight diseases. Increasing incidence of blood cancer, rising number of patients showing response failure to alternative therapies, and growing preference for targeted therapies are major factors driving the growth of the global CAR T Cell Therapy market. Cancer is a prominent cause of death worldwide. According to the World Health Organization, cancer accounted for nearly 10 million deaths in 2020. An estimated 1.24 million blood cancer cases occur yearly worldwide, accounting for approximately 6% of all cancer cases. There are three main types of blood cancers: leukemia, lymphoma, and multiple. Lymphoma accounted for a significant share, followed by leukemia and multiple. CAR T-cell therapy is also being studied in the treatment of other types of cancer. Rapid advances and growth of CAR T-cell therapy are exceeding the expectations.  
According to Value Market Research, the global CAR T Cell Therapy market size was valued at about USD 400 million in 2020 and is estimated to grow at a CAGR of around 45 % during the forecast period 2021 to 2027.
 
Rising approvals by regulatory for research, strong efficacy data in clinical trials, and rapid expansion of investigative pipeline are expected to create ample opportunities in the global market. However, the availability of other alternative therapeutics and the threat of potential post side effects hamper the global market growth to a large extend. Chemotherapy and radiotherapy are primary for preference for treating any cancer disease. CAR T-cell therapy is yet to gain acceptance due to low probability of survival, low awareness, and shortage of specialists performing a treatment. CAR T-cell therapy also causes several problematic and sometimes fatal side effects. One of the most common is cytokine release syndrome (CRS) and B cells' mass die-off. Another severe and potentially fatal side effect noticed is swelling in the brain or cerebral edema. 
 
Novartis International AG, Kite Pharma, Inc., Juno Therapeutics, Bluebird Bio, Inc., Sorrento Therapeutics Inc., Mustang Bio, Inc., Aurora Biopharma Inc., Legend Biotech, Pfizer, Inc., and CARsgen Therapeutics, Ltd. are key companies operating in the global CAR T Cell Therapy market. Key market companies are engaged in extensive research and development of new targeted cell therapies in the market. Moreover, key players adopt merger and acquisition strategies to pace the research activities and enhance share in the global CAR T Cell Therapy market.

Global CAR T Cell Therapy Market Share
 
In this research report, the global CAR T Cell Therapy market is segmented by target antigen, therapeutic application, and region.
 
Analysis, By Target Antigen
By target antigen, the global CAR T Cell Therapy market is divided into CD19, CD20, GD2, CD22, CD30, CD33, HER1, HER2, and others. CD19 grabbed 45% of the global CAR T Cell Therapy market by target antigen type due to a strong response rate. CD-19 specific CAR-T therapy has induced high initial response rates and a strong signal for efficacy in blood cancer patients. CD20 and CD30 are other prominent segments of the market. CD20 and CD30 are widely studied for their response towards curing conditionsThey are considered potential targets by pharmaceutical companies and research organizations. Trials have been ongoing in this direction and showing success as well. 
 
Analysis, By Therapeutic Application
By therapeutic application, the global CAR T Cell Therapy market is segmented into acute lymphocytic leukemia, chronic lymphocytic leukemia, diffuse large B-cell lymphoma, acute myeloid leukemia, multiple myeloma, pancreatic cancer, neuroblasta, breast cancer, hepatocellular, carcinoma, colorectal cancer, and others. Among these, diffuse large B-cell lymphoma (DLBCL) accounted for the largest share. CAR T Cell Therapy is primarily used for treating blood cancer. Diffuse large B-cell lymphoma (DLBCL) is the most common type of blood cancer, representing 30% of all lymphoma cases. CAR T Cell Therapy has shown promising efficacy in patients with DLBCL. 
 
Analysis, By Region
Based on region, the global CAR T Cell Therapy market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is dominating the global CAR T Cell Therapy market with a 40 % share. This is due to a rapid increase in cancer burden, the presence of many prominent players, the availability of skilled professionals, vital healthcare and medical research infrastructure, and rapid treatment by key players. Europe is the second-largest market for CAR T Cell Therapy. Asia Pacific region will grow with the emerging participation of companies in the CAR T Cell Therapy research and rising interest in adopting treatment on the patients. 
 
Market Segmentation covered in the Report:
By Target Antigen
  • CD 19
  • CD 20
  • CD 138
  • GD2
  • CD22
  • CD30
  • CD33
  • HER1
  • HER2
  • Others
 
By Therapeutic Application
  • Acute Lymphocytic Leukemia
  • Chronic Lymphocytic Leukemia
  • Diffuse Large B-Cell Lymphoma
  • Acute Myeloid Leukemia
  • Multiple Myeloma
  • Pancreatic Cancer
  • Neuroblasta
  • Breast Cancer
  • Hepatocellular
  • Carcinoma
  • Colorectal Cancer
  • Others
 
By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

METHODOLOGY

This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications. 

If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization. 

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . CAR T CELL THERAPY – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Target Antigen
           3.7.2 By Therapeutic Application
           3.7.3 By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL CAR T CELL THERAPY MARKET ANALYSIS BY TARGET ANTIGEN
       6.1 Overview by Target Antigen
       6.2 Historical and Forecast Data
       6.3 Analysis by Target Antigen
       6.4 CD 19 Market by Regions
       6.6 CD 20 Market by Regions
       6.5 CD 138 Market by Regions
       6.7 GD2 Market by Regions
       6.8 CD22 Market by Regions
       6.9 CD30 Market by Regions
       6.10. CD33 Market by Regions
       6.11 HER1 Market by Regions
       6.12 HER2 Market by Regions
       6.13 Others Market by Regions
 
7 . GLOBAL CAR T CELL THERAPY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
       7.1 Overview by Therapeutic Application
       7.2 Historical and Forecast Data
       7.3 Analysis by Therapeutic Application
       7.4 Acute Lymphocytic Leukemia Market by Regions
       7.5 Chronic Lymphocytic Leukemia Market by Regions
       7.6 Diffuse Large B-Cell Lymphoma Market by Regions
       7.7 Acute Myeloid Leukemia Market by Regions
       7.8 Multiple Myeloma Market by Regions
       7.9 Pancreatic Cancer Market by Regions
       7.10. Neuroblasta Market by Regions
       7.11 Breast Cancer Market by Regions
       7.12 Hepatocellular Market by Regions
       7.13 Carcinoma Market by Regions
       7.14 Colorectal Cancer Market by Regions
 
8 . GLOBAL CAR T CELL THERAPY MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview, Historic and Forecast Data
           8.3.2. North America By Segment
           8.3.3. North America By Country
           8.3.4. United State
           8.3.5. Canada
           8.3.6. Mexico
       8.4. Europe
           8.4.1. Overview, Historic and Forecast Data
           8.4.2. Europe by Segment
           8.4.3. Europe by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7. Italy
           8.4.8. Russia
           8.4.9. Rest Of Europe
       8.5. Asia Pacific
           8.5.1. Overview, Historic and Forecast Data
           8.5.2. Asia Pacific by Segment
           8.5.3. Asia Pacific by Country
           8.5.4. China
           8.5.5. India
           8.5.6. Japan
           8.5.7. South Korea
           8.5.8. Australia
           8.5.9. Rest Of Asia Pacific
       8.6. Latin America
           8.6.1. Overview, Historic and Forecast Data
           8.6.2. Latin America by Segment
           8.6.3. Latin America by Country
           8.6.4. Brazil
           8.6.5. Argentina
           8.6.6. Peru
           8.6.7. Chile
           8.6.8. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview, Historic and Forecast Data
           8.7.2. Middle East & Africa by Segment
           8.7.3. Middle East & Africa by Country
           8.7.4. Saudi Arabia
           8.7.5. UAE
           8.7.6. Israel
           8.7.7. South Africa
           8.7.8. Rest Of Middle East And Africa
 
9 . COMPETITIVE LANDSCAPE OF THE CAR T CELL THERAPY COMPANIES
       9.1. Car T Cell Therapy Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF CAR T CELL THERAPY INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Novartis International AG
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Kite Pharma, Inc.
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Juno Therapeutics
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Bluebird Bio, Inc.
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Sorrento Therapeutics Inc.
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Mustang Bio, Inc.
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Aurora Biopharma Inc.
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Legend Biotech, Pfizer, Inc.
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. CARsgen Therapeutics, Ltd.
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
 LIST OF TABLES
 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Target Antigen (USD MN)
  •  CD 19 Market by Geography (USD MN)
  •  CD 20 Market by Geography (USD MN)
  •  CD 138 Market by Geography (USD MN)
  •  GD2 Market by Geography (USD MN)
  •  CD22 Market by Geography (USD MN)
  •  CD30 Market by Geography (USD MN)
  •  CD33 Market by Geography (USD MN)
  •  HER1 Market by Geography (USD MN)
  •  HER2 Market by Geography (USD MN)
  •  Others Market by Geography (USD MN)
  •  Analysis Market by Therapeutic Application (USD MN)
  •  Acute Lymphocytic Leukemia Market by Geography (USD MN)
  •  Chronic Lymphocytic Leukemia Market by Geography (USD MN)
  •  Diffuse Large B-Cell Lymphoma Market by Geography (USD MN)
  •  Acute Myeloid Leukemia Market by Geography (USD MN)
  •  Multiple Myeloma Market by Geography (USD MN)
  •  Pancreatic Cancer Market by Geography (USD MN)
  •  Neuroblasta Market by Geography (USD MN)
  •  Breast Cancer Market by Geography (USD MN)
  •  Hepatocellular Market by Geography (USD MN)
  •  Carcinoma Market by Geography (USD MN)
  •  Colorectal Cancer Market by Geography (USD MN)
  •  Global Car T Cell Therapy Market by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton
 
 LIST OF FIGURES
 
  •  Research Scope of Car T Cell Therapy Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Car T Cell Therapy Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Target Antigen
  •  Market Attractiveness Analysis by Therapeutic Application
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Target Antigen (USD MN)
  •  CD 19 Market by Geography (USD MN)
  •  CD 20 Market by Geography (USD MN)
  •  CD 138 Market by Geography (USD MN)
  •  GD2 Market by Geography (USD MN)
  •  CD22 Market by Geography (USD MN)
  •  CD30 Market by Geography (USD MN)
  •  CD33 Market by Geography (USD MN)
  •  HER1 Market by Geography (USD MN)
  •  HER2 Market by Geography (USD MN)
  •  Others Market by Geography (USD MN)
  •  Global Market Analysis by Therapeutic Application (USD MN)
  •  Acute Lymphocytic Leukemia Market by Geography (USD MN)
  •  Chronic Lymphocytic Leukemia Market by Geography (USD MN)
  •  Diffuse Large B-Cell Lymphoma Market by Geography (USD MN)
  •  Acute Myeloid Leukemia Market by Geography (USD MN)
  •  Multiple Myeloma Market by Geography (USD MN)
  •  Pancreatic Cancer Market by Geography (USD MN)
  •  Neuroblasta Market by Geography (USD MN)
  •  Breast Cancer Market by Geography (USD MN)
  •  Hepatocellular Market by Geography (USD MN)
  •  Carcinoma Market by Geography (USD MN)
  •  Colorectal Cancer Market by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Company Market Share Analysis, 2020
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials